Condition: Coronary Artery Disease · Sponsor: Samsung Medical Center
A pragmatic, prospective, multi-center, open label, randomized controlled, superiority trial. The study will compare clinical outcomes between invasive versus non-invasive approach as next diagnostic step in symptomatic patients with non-high risk obstructive coronary artery disease (CAD) on coronary computed tomography-angiography (CCTA).
This description comes directly from the study's public registry record.
Joo Myung Lee, MD, MPH, PhD · 82-2-3410-3391 · drone80@hanmail.net
David Hong, MD · 82-2-3410-3391 · hongdawi@naver.com
Always discuss trial participation with your own doctor first.
| SoonChunHyang University Hospital Bucheon | Bucheon-si, South Korea | Recruiting |
| Kangwon National University Hospital | Chuncheon, South Korea | Recruiting |
| Chungbuk National University Hospital | Chungju, South Korea | Recruiting |
| Keimyung University Dongsan Medical Center | Daegu, South Korea | Recruiting |
| Kyungpook National University Hospital | Daegu, South Korea | Recruiting |
| Chungnam National University Hospital | Daejeon, South Korea | Recruiting |
| Chonnam National University | Gwangju, South Korea | Recruiting |
| Chung-Ang University Gwangmyeong Hospital | Gwangmyeong, South Korea | Recruiting |
| Inje university Ilsan Paik hospital | Ilsan, South Korea | Recruiting |
| Gachon University Gil Medical Center | Incheon, South Korea | Recruiting |
| Kwandong University Intl. ST. Mary's Hospital | Incheon, South Korea | Recruiting |
| Gyeongsang National University Hospital | Jinju, South Korea | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05799092